Editas Medicine, Inc. (EDIT) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $40.52M | +25.4% |
| 2024 | $32.31M | -58.6% |
| 2023 | $78.12M | +296.3% |
| 2022 | $19.71M | -22.8% |
| 2021 | $25.54M | -71.8% |
| 2020 | $90.73M | +341.9% |
| 2019 | $20.53M | -35.7% |
| 2018 | $31.94M | +132.6% |
| 2017 | $13.73M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $40.52M | +25.4% |
| 2024 | $32.31M | -58.6% |
| 2023 | $78.12M | +296.3% |
| 2022 | $19.71M | -22.8% |
| 2021 | $25.54M | -71.8% |
| 2020 | $90.73M | +341.9% |
| 2019 | $20.53M | -35.7% |
| 2018 | $31.94M | +132.6% |
| 2017 | $13.73M | — |